Skip to main content

Table 1 The characteristics of patients before and after PSM

From: Association between intraoperative mean arterial pressure variability and postoperative delirium after hip fracture surgery: a retrospective cohort study

Characteristic

Before PSM (n = 963)

After PSM (3:1) (n = 628)

MAPV ≤ 2.17 (n = 716)

MAPV > 2.17 (n = 247)

SMD

MAPV ≤ 2.17 (N = 471)

MAPV > 2.17 (n = 157)

SMD

Age, year

79.0 (73.0,84.0)

80.0 (73.0,85.0)

0.076

81.0 (75.0, 85.0)

81.0 (74.0, 85.0)

0.001

Sex (female), n (%)

534 (74.6)

195 (78.9)

0.104

353 (74.9)

123 (78.3)

0.080

BMI, kg/m2

22.6 (19.5,25.4)

23.4 (20.8,25.7)

0.171

22.9 (19.6, 25.8)

23.4 (20.6, 25.4)

0.034

Smoking, n (%)

59 (8.2)

18 (7.3)

0.036

44 (9.3)

14 (8.9)

0.015

ASA stage (> II), n (%)

359 (50.1)

154(62.3)

0.248

279 (59.2)

92 (58.6)

0.013

Alcohol consumption, n (%)

43 (6.0)

15 (6.1)

0.003

28 (5.9)

9 (5.7)

0.009

Major coexisting conditions

 COPD, n (%)

42 (5.9)

5 (2.0)

0.198

18 (3.8)

4 (2.5)

0.073

 Diabetes mellitus, n (%)

246 (34.4)

88 (35.6)

0.027

167 (35.5)

56 (35.7)

0.004

 Hypertension, n (%)

389 (54.3)

133 (53.8)

0.010

259 (55.0)

83 (52.9)

0.043

 Cardiovascular diseases, n (%)

144 (20.1)

47 (19.0)

0.027

103 (21.9)

30 (19.1)

0.068

 Cerebrovascular disease, n (%)

154 (21.5)

78 (31.6)

0.230

121 (25.7)

40 (25.5)

0.005

 Dementia

12 (1.7)

8 (3.2)

0.101

7 (1.5)

3 (1.9)

0.033

Surgical conditions

 Anesthesia method, n (%)

  

0.698

  

0.015

  Regional

481 (67.2)

99 (40.1)

 

274 (58.2)

92 (58.6)

 

  General

115 (16.1)

114 (46.2)

 

114 (24.2)

37 (23.6)

 

  Regional + General

120 (16.8)

34 (13.8)

 

83 (17.6)

28 (17.8)

 

 Fracture type, n (%)

  

0.093

  

0.041

  Intertrochanteric

311 (43.4)

96 (38.9)

 

202 (42.9)

70 (44.6)

 

  Femoral neck

400 (55.9)

149 (60.3)

 

264 (56.1)

85 (54.1)

 

  multiple locations

5 (0.7)

2 (0.8)

 

5 (1.1)

2 (1.3)

 

 Duration of surgery, min

100.0 (80.0,120.0)

95.0 (75.0,120.0)

0.024

100.0 (80.0, 120.0)

95.0 (75.0, 115.0)

0.076

 Emergency surgery, n (%)

14 (2.0)

4 (1.6)

0.025

9 (1.9)

2 (1.3)

0.051

Drug usage

 Benzodiazepines, n (%)

462 (64.5)

151 (61.1)

0.070

294 (62.4)

92 (58.6)

0.078

 Dexmedetomidine, n (%)

156 (21.8)

39 (15.8)

0.154

84 (17.8)

29 (18.5)

0.017

 Glucocorticoids, n (%)

213 (29.7)

104 (42.1)

0.260

161 (34.2)

57 (36.3)

0.044

 Droperidol, n (%)

99 (13.8)

26 (10.5)

0.101

63 (13.4)

18 (11.5)

0.058

Preoperative blood test

 WBC count, ×109/L

6.9 (5.6, 8.6)

7.2 (5.5, 8.4)

0.009

6.9 (5.5, 8.6)

7.0 (5.5, 8.8)

0.024

 RBC count, ×1012/L

3.8 (3.4, 4.2)

3.8 (3.4, 4.2)

0.021

3.8 (3.4, 4.1)

3.8 (3.3, 4.1)

0.059

 Platelet, ×109/L

215.0 (167.8,265.0)

222.0 (170.0,270.0)

0.038

216.0 (167.0, 266.5)

220.0 (171.0, 270.0)

0.019

 Albumin, g/L

34.9 (32.2, 37.7)

34.8 (32.4, 38.0)

0.004

34.9 (32.4, 37.6)

34.3 (32.5, 37.6)

0.051

 Creatinine, μmol/L

64.2 (54.3, 76.3)

63.70 (53.5, 78.6)

0.079

64.8 (55.3, 78.7)

63.5 (52.9, 78.7)

0.041

 Hemoglobin, g/L

115.0 (103.0, 126.0)

116.0 (103.0,127.5)

0.019

114.0 (103.0, 126.0)

115.0 (101.0, 127.0)

0.065

Postoperative conditions

 POD, n (%)

64 (8.9)

51 (20.6)

0.334

50 (10.6)

37 (23.6)

0.349

  1. SMD Standardized mean difference, PSM Propensity Score Matching, BMI Body mass index, COPD Chronic obstructive pulmonary disease, ASA American Society of Anesthesiologists physical status, RBC Red blood cell, WBC White blood cell, POD Postoperative delirium